Lisa Argnani - Dissemin

Papers authored by Lisa Argnani

This paper is made freely available by the publisher.

2017 Alessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, Benedetta Puccini, Caterina Patti, Guido Gini, Donato Mannina, Monica Tani, Chiara Rusconi, Alessandra Romano, Anna Vanazzi, Barbara Botto, Carmelo Carlo-Stella, Stefan Hohaus, Pellegrino Musto and 27 other authors

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

Download from doi.org

Cinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, Luigi Rigacci, Caterina Patti, Guido Gini, Donato Mannina, Monica Tani, Chiara Rusconi, Alessandra Romano, Anna Vanazzi, Barbara Botto, Armando Santoro

, Stefan Hoaus, Gian Matteo Rigolin and 27 other authors

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma

Download from doi.org

Alessandro Broccoli, Beatrice Casadei, Vittorio Stefoni, Cinzia Pellegrini, Federica Quirini, Lorenzo Tonialini, Alice Morigi, Miriam Marangon, Lisa Argnani

, Pier Luigi Zinzani

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Alessandro Broccoli

, Lisa Argnani

, Vittorio Stefoni, Letizia Gandolfi, Pier Luigi Zinzani

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis

Upload

Pier Luigi Zinzani, Cinzia Pellegrini, Annalisa Chiappella, Alice Di Rocco, Flavia Salvi, Maria Giuseppina Cabras, Lisa Argnani

, Vittorio Stefoni

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Download from www.bloodjournal.org

Francesco Malaspina, Cinzia Pellegrini, Beatrice Casadei, Lisa Argnani

, Pier Luigi Zinzani

Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma

Upload

2016 Lisa Argnani

, Alessandro Broccoli, Cinzia Pellegrini, Beatrice Casadei, Pier Luigi Zinzani

Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice

Upload

Claudio Agostinelli, Andrea Gallamini, Luisa Stracqualursi, Patrizia Agati, Claudio Tripodo, Fabio Fuligni, Maria Teresa Sista, Stefano Fanti, Alberto Biggi, Umberto Vitolo, Luigi Rigacci, Francesco Merli, Caterina Patti, Alessandra Romano, Alessandro Levis and 19 other authors

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Letizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei, Vittorio Stefoni, Alessandro Broccoli, Lorenzo Tonialini, Alice Morigi, Lisa Argnani

, Pier Luigi Zinzani

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Upload

Pier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, Liliana Devizzi, Alberto Fabbri, Francesco Zaja, Alice Di Rocco, Giuseppe Rossi, Sergio Storti, Pier Paolo Fattori, Lisa Argnani

, Umberto Vitolo

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study

Download from tandfonline.com

P. L. Zinzani, C. Pellegrini, L. Argnani

, A. Broccoli

Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab

Download from doi.org

V. Stefoni, B. Casadei, C. Bottelli, G. Gaidano, C. Ciochetto, M. G. Cabras, M. Ansuinelli, L. Argnani

, A. Broccoli, L. Gandolfi, C. Pellegrini, P. L. Zinzani

Short-course R-CHOP followed by 90Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

Download from doi.org

Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Federico Monaco, Debora Degl'Innocenti, Flavia Salvi, Umberto Vitolo, Lisa Argnani

, Paolo Corradini, Pier Luigi Zinzani, Fil) On behalf of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi Onlus

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

Download from doi.org

Lisa Argnani

, Pier Luigi Zinzani

Reporting real‐life experience with drugs in lymphoma patients

Upload

Alessandro Broccoli, Letizia Gandolfi, Cinzia Pellegrini, Claudio Agostinelli, Lisa Argnani

, Pier Luigi Zinzani

Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature

Upload

Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni, Giorgia Annechini, Amalia De Renzo, Vittorio Stefoni, Alessandro Broccoli, Letizia Gandolfi, Federica Quirini, Lorenzo Tonialini, Alice Morigi, Lisa Argnani

, Pier Luigi Zinzani

90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years

Download from doi.org

Pier Luigi Zinzani, Alessandro Broccoli, Daniela Maria Gioia, Antonio Castagnoli, Giovannino Ciccone, Andrea Evangelista, Armando Santoro

, Umberto Ricardi, Maurizio Bonfichi, Ercole Brusamolino, Giuseppe Rossi, Antonella Anastasia, Francesco Zaja, Umberto Vitolo, Vincenzo Pavone and 13 other authors

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study

Download from doi.org